Clinical implementation of a new electronic brachytherapy system for skin brachytherapy

Journal of Contemporary Brachytherapy

Volumn 6, Issue 4, 2014, Pages 417-423

  Pons Llanas, Olga ^a   Ballester Sánchez, Rosa ^a   Celada Álvarez, Francisco Javier ^a   Candela Juan, Cristian ^a   García Martínez, Teresa ^b   Llavador Ros, Margarita ^a   Botella Estrada, Rafael ^a   Barker, Christopher A ^c   Ballesta, Antonio ^a   Tormo Micó, Alejandro ^a   Rodríguez, Silvia ^d   Perez Calatayud, Jose ^a,d  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b Hospital La Ribera   (Spain)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d Hospital Clinica Benidorm   (Spain)

Author keywords

Basal cell carcinoma; Electronic brachytherapy; Esteya; Fractionation; Patient setup; Skin cancer

Indexed keywords

BASAL CELL CARCINOMA; BRACHYTHERAPY; ELECTRONIC BRACHYTHERAPY; HUMAN; OUTCOME ASSESSMENT; PATIENT SELECTION; QUALITY CONTROL; RADIATION DOSE FRACTIONATION; RADIOTHERAPY EQUIPMENT; REVIEW; SKIN SURFACE; TREATMENT PLANNING;

EID: 84920475246     PISSN: 1689832X     EISSN: None     Source Type: Journal    
DOI: 10.5114/jcb.2014.47996     Document Type: Review

References (33)

1. Lear W, Dahlke E, Murray CA. Basal cell carcinoma: review of epidemiology, pathogenesis, and associated risk factors. J Cutan Med Surg 2007; 11: 19-30.
2. Clark CM, Furniss M, Mackay-Wiggan JM. Basal cell carcinoma: an evidence-based treatment update. Am J Clin Derm 2014; 15: 197-216.
3. Bahner JD, Bordeaux JS. Non-melanoma skin cancers: pho-todynamic therapy, cryotherapy, 5-fuorouracil, imiquimod, diclofenac, or what? Facts and controversies. Clin Dermatol 2013; 31: 792-798.
4. Fimhaber JM. Diagnosis and treatment of basal cell and squa-mous cell carcinoma. Am Fam Physician 2012; 86: 161-168.
5. Ormerod A, Rajpara S, Craig F. Basal cell carcinoma. Clin Evid (Online) 2010; 6: 1719.
6. Roozeboom MH, Arits AH, Nelemans PJ et al. Overall treatment success after treatment of primary superfcial basal cell carcinoma: a systematic review and meta-analysis of randomized and nonrandomized trials. Br J Dermatol 2012; 167: 733-756.
7. National Comprehensive Cancer Network guidelines 2013 of Basal Cell Skin Cancer.
8. Tormo A, Celada F, Rodriguez S et al. Non-melanoma skin cancer treated with HDR Valencia applicator: clinical outcomes. J Contemp Brachytherapy 2014; 6: 167-172.
9. García-Martínez T, Chan J-P, Perez-Calatayud J et al. Do-simetric characteristics of a new unit for electronic skin brachytherapy. J Contemp Brachytherapy 2014; 6: 1-9.
10. Granero D, Perez-Calatayud J, Jimeno J et al. Design and evaluation of a HDR skin applicator with fattening flter. Med Phys 2008; 35: 495-503.
11. AJCC (American Joint Committee on Cancer). Cancer staging of cutaneus nonmelanoma skin cancer. 2010.
12. Hernández C, del Boz J, de Troya M. Can high-frequency skin ultrasoud be used for the diasgnosis and management of basal cell carcinoma? Actas Dermo-sifliográfcas 2014; 105: 107-111.
13. Nassiri-Kashani M, Sadr B, Fanian F et al. Pre-operative assessment of basal cell carcinoma dimensions using high frequency ultrasonography and its correlation with histopathol-ogy. Skin Res Techn 2013; 19: e132-e138.
14. Ballester R, Pons O, Llavador M et al. Depth determination of superfcial brachytherapy: Ultrasound vs Histophatology. J Contemp Brachytherapy 2014 [In press].
15. Nag S, Quivey JM, Earle JD et al. The American Brachythera-py Society recommendations for brachytherapy of uveal melanomas. Int J Radiat Oncol Biol Phys 2003; 56: 544-555.
16. Bhatnagar A. Nonmelanoma skin cancer treated with electronic brachytherapy: results at 1 year. Brachytherapy 2013; 12: 134-140.
17. Gauden S, Egan C, Pracy M. HDR brachytherapy for the treatment of the skin cancer using standard surface applicators. Brachytherapy 2008; 7: 159 (Abstract).
18. Ghaly M, Zinkin H, Dannenberg M et al. HDR brachythera-py with standardized surface applicators in the treatment of superfcial malignant skin lesions. Int J Radiat Oncol Biol Phys 2008; 72: 505-506.
19. Khan L, Choo R, Bree D et al. Recommendations for CTV margins in radiotherapy planning for non melanoma skin cancer. Radiother Oncol 2012; 104: 263-266.
20. Caresana G, Giardini R. Dermoscopy-guided surgery in basal cell carcinoma. J Eur Acad Dermatol Venereol 2010; 24: 1395-1399.
21. Ballester R, Pons O, Perez-Calatayud J et al. Dermoscopy margin delineation in radiotherapy planning for superf-cial and nodular basal cell carcinoma. Br J Dermatol 2014 [In press].
22. Giacomel J, Zalaudek I. Dermoscopy of Superfcial Basal Cell Carcinoma. Derm Surg 2005; 3: 1710-1713.
23. Ellis F. Dose, time, and fractionation: a clinical hypothesis. Clin Radiol 1969; 20: 1-7.
24. Dale RG. The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy. Br J Radiol 1985; 58: 515-528.
25. Strandquist M. A study of the cumulative effects of fractionated X-ray treatment based on the experience gained at radiumhemmet with the treatment of cases of carcinoma of the skin and lip. Acta Radiol 1944; 55 (Suppl): 300-304.
26. Potter R, Haie Meder C, van Limbergen E et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, and radiobiology. Radiother Oncol 2006; 78: 67-77.
27. Onishi H, Araki T, Shirato H et al. Stereotactic hypofraction-ated high-dose irradiation for stage I non-small cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multi-institutional study. Cancer 2004; 101: 1623-1631.
28. Trott KR, Maciejewski B, Preuss-Bayer G et al. Dose-response curve and split-dose recovery in human skin cancer. Radioth-er Oncol 1984; 2: 123-129.
29. Turesson I, Thames HD. Repair capacity and kinetics of human skin during fractionated radiotherapy: erythema, desquamation, and telangiectasia after 3 and 5 year's follow-up. Radiother Oncol 1989; 15: 169-188.
30. Amendola B et al. Dermatological applications of HDR using surface applicators using a shorter treat-ment schedule. Brachytherapy 2006; 5: 105 (Abstract).
31. Fabrini MG, Perrone F, De Liguoro M et al. High dose rate brachytherapy in a large squamous cell carcinoma of the hand. Brachytherapy 2008; 7: 270-275.
32. European Society for Therapeutic Radiology and Oncology. ESTRO booklet No. 8: A practical guide to quality control of brachytherapy equipment. Venselaar J, Perez-Calatayud J (eds.). Brussels, 2004.
33. Esteya Electronic Brachytherapy System U87001-User Manual. Doc. No. 777.00193MAN-02DRAFT-374A, 2014.